New Drug Approvals

Home | Pages | Archives

TaiGen Biotechnology Announces Submission of New Drug Application for Nemonoxacin in Taiwan and Mainland china

May 16, 2013 7:25 am

nemonoxacin malate

TAIPEI, Taiwan, May 16, 2013

TaiGen Biotechnology Company, Limited (“TaiGen”) today announced that they have submitted New Drug Application (NDA) for the oral formulation of nemonoxacin with the Taiwan Food and Drug Administration (TFDA) and China Food and Drug Administration (CFDA). Approval is expected in the first half of 2014.

Read more here: http://www.heraldonline.com/2013/05/16/4866550/taigen-biotechnology-announces.html

Posted by DR ANTHONY MELVIN CRASTO Ph.D

Categories: china pipeline

Tags: nemonoxacin, TaiGen Biotechnology Company

« Older Newer »

Leave a Reply

Mobile Site | Full Site

Get a free blog at WordPress.com Theme: WordPress Mobile Edition by Alex King.